https://www.investorideas.com/About/ Investorideas.com is a trusted platform for retail investors, serving as a hub for innovative investing ideas for over 25 years. Known for its pioneering coverage of sectors like mining,…
soars
-
-
Black Hills makes the NYSE top gainers list after signing agreements through 2048 to serve a planned Google data center in Cheyenne, Wyoming. Investorideas.com (www.investorideas.com newswire) a trusted platform for…
-
Investment
AI Stock Firefly Neuroscience (NASDAQ: AIFF) Soars on First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD
A new partnership pairs Firefly’s AI-powered Evoke EEG/ERP platform with NeuroSigma’s Monarch eTNS System, the first FDA-cleared non-drug treatment for pediatric ADHD. Investorideas.com (www.investorideas.com) a trusted platform for investing ideas…
-
The launch of OpenAI’s ChatGPT created a major buzz around artificial intelligence (AI) stocks. ChatGPT is an AI chatbot software application that uses machine-learning techniques to emulate human-written conversations. This…
-
Highway 50 Gold Corp. (TSXV: HWY) surges after announcing a large-scale gold discovery at its 100%-owned Gold Knob project in north-central Nevada. Investorideas.com (www.investorideas.com), a leader in mining investing news…
-
Investment
RedHill Biopharma (NASDAQ: RDHL) Soars to $1.60 – Monetizes Talicia Stake in $18 Million Cash Deal With Apotex
Biotech · Trading Alert NASDAQ: RDHL Shares surged after RedHill divested its Talicia gastrointestinal business to a subsidiary of Apotex Health Corp. for $18 million upfront, with up…
-
The AI cloud provider topped revenue and earnings expectations, with its CEO cheering “an important inflection point.”
-
Investment
IAMGOLD (NYSE: IAG) (TSX: IMG) Soars on Second Quarter News; Gold Investors Back in the Game
IAMGOLD shares jump on the TSX after strong second-quarter production and adjusted EBITDA, with CEO Renaud Adams pointing to Cote Gold’s expanding long-term potential. Investorideas.com (www.investorideas.com newswire), a leader in…
-
Investment
Tvardi Therapeutics (Nasdaq: TVRD) Soars on Positive Phase 1 Results for Next-Gen STAT3 Inhibitor TTI-109
Tvardi’s next-generation STAT3 inhibitor TTI-109 confirmed rapid prodrug conversion, dose-proportional exposure, and improved tolerability versus TTI-101 in Phase 1 testing. Investorideas.com (www.investorideas.com) a trusted platform for investing ideas, including biotech…
-
Technology · Stock Alert NASDAQ: KEEL Keel Infrastructure, formerly Bitfarms, jumps on the TSX gainers list as it pivots from Bitcoin mining to AI and high-performance computing infrastructure.…
